Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse DCAMKL1 ELISA Kit (AC3264)
Cat.#: ASET-1853
Specifications
Description Mouse DCAMKL1 ELISA Kit allows for the in vitro quantitative determination of mouse DCAMKL1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2258 Human CBLN2 ELISA Kit (AC3669) Quantitative inquiry ASET-1111 Human HAGH ELISA Kit (AC2522) Quantitative inquiry ASET-1243 Mouse Kisspeptin ELISA Kit (AC2654) Quantitative inquiry ASET-1417 Mouse Adenosine Receptor A2a ELISA Kit (AC2828) Quantitative inquiry ASET-1939 Mouse FOXO1A ELISA Kit (AC3350) Quantitative inquiry ASET-1051 Human LAMP1 ELISA Kit (AC2462) Quantitative inquiry ASET-2447 Human Neuropilin 1 ELISA Kit (AC3858) Quantitative inquiry ASET-1732 Mouse Eph Receptor A2 ELISA Kit (AC3143) Quantitative inquiry ASET-2248 Mouse Dab1 ELISA Kit (AC3659) Quantitative inquiry ASET-1231 Human CDK1 ELISA Kit (AC2642) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket